Skip to search formSkip to main contentSkip to account menu

HU 211

Known as: 6H-Dibenzo(b,d)pyran-9-methanol, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aS-trans)-, HU-211 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
The major psychoactive constituent of Cannabis sativa, Δ9-tetrahydrocannabinol (Δ9-THC), and endogenous cannabinoid ligands, such… 
Highly Cited
2002
Highly Cited
2002
OBJECTIVE To establish the safety of intravenous dexanabinol in severe head injury. DESIGN Prospective, randomized, double… 
2000
2000
Abstract Purpose: To study the ocular hypotensive effect of a nonpsychotropic cannabinoid, HU-211 (11-hydroxy-Δ8-tetra… 
Highly Cited
1998
Highly Cited
1998
The neuroprotective actions of cannabidiol and other cannabinoids were examined in rat cortical neuron cultures exposed to toxic… 
Highly Cited
1995
Highly Cited
1995
BACKGROUND AND PURPOSE HU-211 is a nonpsychotropic cannabinoid analogue that has been shown to act as a functional N-methyl-D… 
Review
1995
Review
1995
HU-211 (Dexanabinol), a putative neuroprotective agent, was evaluated in a number of animal models including closed head injury… 
Highly Cited
1993
Highly Cited
1993
HU-211 is a synthetic, nonpsychotropic cannabinoid, which has been shown to act as a noncompetitive N-methyl-D-aspartate (NMDA…